Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion reported significant progress across its AI-driven clinical pipeline for Q1 ...

Hundreds of packages across npm and PyPI have been compromised in a new Shai-Hulud supply-chain campaign delivering ...

Rise of agentic AI: Autonomous AI systems are moving from reactive tools to proactive agents capable of pursuing goals, reshaping sectors like logistics, healthcare, and finance. Security risks grow: ...

Brand-new startups are continuing to raise massive rounds to work on new niches of AI. Recursive, a stealth-mode AI lab, has emerged ...

Robotics gap closed: UK researchers developed a method to transfer robot skills from simulation to reality using minimal real-world data, reducing cost and risk. Networks learn continuously: ...

More and more experts are saying that AI is beginning to have a significant impact in their domains. Cybersecurity is the latest ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Cybersecurity, Compliance Firm Aims to Make More Businesses Insurable, Recoverable from Cyber Incidents DETROIT, MI, ...

Today Microsoft is announcing a major step forward in AI-powered cyber defense: a new multi-model agentic scanning harness ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion Pharmaceuticals’ latest earnings call struck a cautiously optimistic tone as management highlighted its first AI-enabled clinical proof-of-concept, major cost cuts, and an extended cash ...